Home Featured Page 161

Featured

Latest

Travis Tyler Fluck: Denver Mushroom Decriminalization, Mutual Aid, and the Future of Psychedelic Culture

The War on Drugs Is a War On Mothers and Their Children

Burning Heroes Pitch Competition

Psilocybin for Cocaine Use Disorder: Peter Hendricks on a Trial Ten Years in the Making

PT353 – Dr. James Fadiman, Dr. Sam Gandy, & Dr. David...

Psychedelic Bulletin #117 – A Deep Dive Into Psilocybin for Alochol...

Psychedelic Research Bulletin: July and August 2022

Wesana Announces Sale of Clinic Management Services Organization

MDMA Enhances Fear Extinction Learning: From Models to Mechanisms

PT352 – Alex Enchin & Ian-Michael Hébert, MA – HOLOS: Returning...

Algernon Pharmaceuticals Reports Positive Results from Full Data Set of its...

Looking Forward to Horizons Northwest, This September in Portland

COMPASS Pathways to participate in three upcoming investor events

EDITOR PICKS

Travis Tyler Fluck: Denver Mushroom Decriminalization, Mutual Aid, and the Future...

The War on Drugs Is a War On Mothers and Their...

Burning Heroes Pitch Competition

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Travis Tyler Fluck: Denver Mushroom Decriminalization, Mutual Aid, and the Future of Psychedelic Culture

The War on Drugs Is a War On Mothers and Their Children

Burning Heroes Pitch Competition

No Promises and No Goals

Psilocybin for Cocaine Use Disorder: Peter Hendricks on a Trial Ten Years in the Making

PT353 – Dr. James Fadiman, Dr. Sam Gandy, & Dr. David...

Psychedelic Bulletin #117 – A Deep Dive Into Psilocybin for Alochol...

Psychedelic Research Bulletin: July and August 2022

Wesana Announces Sale of Clinic Management Services Organization

MDMA Enhances Fear Extinction Learning: From Models to Mechanisms

PT352 – Alex Enchin & Ian-Michael Hébert, MA – HOLOS: Returning...

Algernon Pharmaceuticals Reports Positive Results from Full Data Set of its...

Looking Forward to Horizons Northwest, This September in Portland

Looking Forward to Horizons Northwest, This September in Portland

COMPASS Pathways to participate in three upcoming investor events

EDITOR PICKS

Travis Tyler Fluck: Denver Mushroom Decriminalization, Mutual Aid, and the Future...

The War on Drugs Is a War On Mothers and Their...

Burning Heroes Pitch Competition

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY